What is confirmed
Hurts' agent, Nicole Lynn, and the Eagles released a joint statement Monday. It says what was first diagnosed as a superficial clot in his calf turned out, after further testing, to be a deep vein thrombosis along with bilateral pulmonary emboli, meaning clots in both lungs.
The statement calls Hurts clinically stable with no significant functional limitations. He cannot take part in football activities while he is on anticoagulation medication. The Eagles expect a full recovery with no long-term effects, and he will stay around the team and keep conditioning.
What insiders are adding
Rapoport says treatment will take at least three months. He also described the clot as provoked, tied to Hurts getting cleated in the calf, which points to a cause doctors can treat. Tom Pelissero of NFL Network says the lung results came back Saturday and that Philadelphia had not yet made any injured reserve decision while it focused on his health.
The fallout in Philadelphia
Tanner McKee started Sunday's 25-14 home loss to Carolina and went 26 of 45 for 215 yards, one touchdown, no interceptions and three sacks. Cole Payton and Joe Milton III, signed off the Dallas practice squad Friday, sit behind him. Andy Dalton, once floated as a possible reunion option, is signing with Atlanta.
What RSO owners should do now
Move Hurts to an IR or reserve slot if your league has one, and plan your 2026 lineups without him. In dynasty and contract formats, the medical outlook is the key fact: a full recovery is expected, so selling him at a panic price makes little sense unless your window is this season only. Owners in rebuild mode can make a cheap offer to a contender who needs the roster spot.
